High dose, subcutaneous injections of benzathine penicillin G (SCIP) to prevent rheumatic fever: A single arm, phase IIa trial of safety and pharmacokinetics (116419)

10:03 AM

Julie Bennett

Plenary 5 - Interventions for Prevention

Setting the scene for Group A Streptococcus vaccine studies: The complete clinical spectrum of severe acute disease is present in Auckland, Aotearoa New Zealand (#117)

5:30 PM

Andrew Fox-Lewis

Poster Session 1

Human serological assays characterization to evaluate the response against Group A Streptococcus vaccine in clinical trial sera (#194)

5:30 PM

Omar Rossi

Poster Session 1

Subcutaneous injections of penicillin: Convenient and effective treatment for Māori, Pacific Peoples and their whānau in preventing rheumatic heart disease (#273)

5:30 PM

Julie Cooper

Poster Session 2

Growing evidence for Group A Streptococcus skin infections as a cause of acute rheumatic fever (117843)

9:42 AM

Michael G Baker

Plenary 7 - Autoimmunity and Its Long Tail

Tracking the relationship between community Strep A infections and Acute Rheumatic Fever in Auckland, New Zealand: 2018-2024 (#103)

5:30 PM

Julie Bennett

Poster Session 1

"iSOoTH: A study on children's sore throats to inform the development of a Group A Streptococcal vaccine (#166)

5:30 PM

Julie Bennett

Poster Session 1

Immune Responses In Siblings With Acute Rheumatic Fever – A Case Study (#219)

5:30 PM

Natalie Lorenz

Poster Session 2

System Serology Reveals Correlates of Functional Group A Streptococcus Antibody Responses In Children With Pharyngitis (#185)

5:30 PM

Reuben McGregor

Poster Session 1

Autoantigen biomarker discovery for acute rheumatic fever: Application of protein fragment bead arrays to cohort studies in Aotearoa New Zealand and Australia (118403)

10:06 AM

Lauren Carlton

Plenary 7 - Autoimmunity and Its Long Tail

Profiling inflammatory resolution over 6 months in acute rheumatic fever (#222)

5:30 PM

Francis M Middleton

Poster Session 2

Building laboratory capacity to advance Strep A vaccine development in Aotearoa New Zealand (#189)

5:30 PM

Aimee Paterson

Poster Session 1

Identification of a perturbed T cell compartment that underlies rheumatic fever pathogenesis in a trans-Tasman study (118448)

12:20 PM

Francis M Middleton

Plenary 2 - New Insights and New Tools

The Emergence and Impact of M1_UK on Invasive Group A Streptococcus Disease in Aotearoa New Zealand (#154)

5:30 PM

Anna Vesty

Poster Session 1

Rapua te mea nagro ka tau- a qualitative, Indigenous-informed approach to vaccine development. (118028)

2:42 PM

Anneka Anderson

Plenary 3 - Big Picture Vaccine Development

Rapua te mea ngaro ka tau: culturally responsive governance applied to vaccine development (#277)

5:30 PM

Shannon Leilua

Poster Session 2

Diverse diagnostic and management approaches for acute rheumatic fever in Australia and New Zealand (#146)

5:30 PM

Anna P Ralph

Poster Session 1